Skip to main content

Table 1 Patient demographics, tumor clinicopathologic features

From: Promoter methylation of ADAMTS1 and BNC1 as potential biomarkers for early detection of pancreatic cancer in blood

  Control (n = 95) Cancer (n = 39) p value (cancer vs control) Pancreatitis (n = 8)
Average age, years (range) 65.5 (21–96) 60.1 (29–83) 0.059 46.6 (29–70)
Gender
 Male (%) 41 (43%) 26 (67%) 0.013 4 (50%)
 Female (%) 54 (57%) 13 (33%)   4 (50%)
Race
 White (%) 22 (23%) 34 (87%)   6 (78%)
 Black (%) 72 (76%) 2 (5%) < 0.05 1 (11%)
 Others (%) 0 (0%) 3 (8%)   1 (11%)
 Not specified (%) 1 (1%) 0 (0%)   0 (0%)
CA 19-9 level* n = 34 N/A n = 1
 Average 665.3
 Median 47.6
 Highest 12,302.5
 Lowest 1 16.1
Smoking status n = 95 n = 39   n = 8
 Never 38 (40%) 22 (56%)   5 (63%)
 Former 40 (42%) 10 (26%) 0.159 3 (38%)
 Current 16 (17%) 7 (18%)   0 (0%)
 Not specified 1 (1%) 0 (0%)   0 (0%)
Average tumor size (range, cm)** 3.2 (0.9–8) N/A
Differentiation   n = 39 N/A  
 Well 1 (3%)
 Moderate 17 (44%)
 Poor 12 (31%)
 Undifferentiated 2 (5%)
 Not specified 7 (18%)
  1. *CA 19-9: five values unavailable for PDAC patient and four unavailable for pancreatitis
  2. **Tumor size: three PDAC, no resection done, N/A: Not applicable